A leading resource for the Pharmaceutical industry since 2002
Astellas will develop and commercialise XNW27011 worldwide, excluding mainland China, Hong Kong, Macao, and Taiwan, in exchange for a $130m upfront payment and up to $1.34bn in milestone payments
Give your business an edge with our leading industry insights.
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry